Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)

The introduction of direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban, apixaban, edoxaban, and betrixaban, provides safe and effective alternative to previous anticoagulant therapies. DOACs directly, selectively, and reversibly inhibit factors IIa or Xa. The coagulation effect foll...

Full description

Bibliographic Details
Main Author:	Claire Dunois
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Biomedicines
Subjects:	DOAC monitoring screening assays quantitative assays
Online Access:	https://www.mdpi.com/2227-9059/9/5/445

Similar Items

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

Preoperative Drug Monitoring in Management of Patients with Hip Fracture on Treatment with Direct Oral Anticoagulants
by: Rostagno C, et al.
Published: (2024-04-01)

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples
by: Eleni A. Linskens, et al.
Published: (2022-02-01)

Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant Testing
by: Paula Savola, et al.
Published: (2022-10-01)

Comparing the Effect of DOAC-Stop® and DOAC-Remove® on Apixaban, Rivaroxaban and Dabigatran Prior to Thrombophilia and Lupus Testing
by: Noor-E.-Huddah Malik, et al.
Published: (2024-10-01)

Risk of Hemorrhoidal Bleeding in Patients Treated with Direct Oral Anticoagulants (DOACs)
by: Carmine Petruzziello, et al.
Published: (2024-07-01)

Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
by: Peter W. Ketch, et al.
Published: (2024-12-01)

Is There a Role for Direct Oral Anticoagulants in the Primary and Secondary Prevention of Myeloproliferative Neoplasm Associated Thrombosis?
by: Uzma Faruqi, et al.
Published: (2021-12-01)

Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study
by: Cristina Legnani, et al.
Published: (2022-12-01)

Update on functional and genetic laboratory assays for the detection of platelet microvesicles
by: Maxime Laroche, et al.
Published: (2017-04-01)

Safety of direct-acting oral anticoagulant (DOAC) prescribing: OpenSAFELY-TPP analysis of 20.5 million adults’ electronic health records
by: Karen Homan, et al.
Published: (2024-07-01)

Use of direct oral anticoagulants in hematologic malignancies
by: Ilona Leviatan, et al.
Published: (2023-12-01)

The use of direct acting oral anticoagulants in patients with COVID-19 infection
by: Ragia Aly, et al.
Published: (2021-03-01)

Could direct-acting oral anticoagulant be a possible cause of delayed pseudoaneurysm? A case report
by: Nurkay Katrancioglu, et al.
Published: (2023-03-01)

Direct oral anticoagulants in cirrhosis: Rationale and current evidenceKeypoints
by: Cindy Pereira Portela, et al.
Published: (2024-08-01)

Changing or Retaining Direct Oral Anticoagulant After Ischemic Stroke Despite Direct Oral Anticoagulant Treatment
by: Shin‐Yi Lin, et al.
Published: (2024-02-01)

Clinical characteristics of patients with direct oral anticoagulant (DOAC) levels outside expected ranges: A retrospective chart study
by: Dionne C.W. Braeken, et al.
Published: (2023-05-01)

Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review
by: Natalia Atzemian, et al.
Published: (2023-09-01)

Dementia risk reduction between DOACs and VKAs in AF: A systematic review and meta‐analysis
by: Anthipa Chokesuwattanaskul, et al.
Published: (2024-10-01)

Direct oral anticoagulants; a review for the non-specialist
by: Thilina Gunawardena
Published: (2021-11-01)

Medication Adherence to Direct Oral Anticoagulants: Extent and Impact of Side Effects
by: van de Steeg BJW, et al.
Published: (2024-08-01)

The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis
by: Fakhar Latif, et al.
Published: (2024-06-01)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
by: Emmanuel J. Favaloro, et al.
Published: (2022-02-01)

Thrombolysis for Ischemic Stroke Despite Recent Ingestion of Direct Oral Anticoagulants – A Growing Dilemma Also in India
by: Thomas R. Meinel, et al.
Published: (2024-08-01)

An update on applications and limitations of direct oral anticoagulants
by: Sharon Wei, et al.
Published: (2023-04-01)

Comparing Efficacy and Safety Between Patients With Atrial Fibrillation Taking Direct Oral Anticoagulants or Warfarin After Direct Oral Anticoagulant Failure
by: Meng‐Tsang Hsieh, et al.
Published: (2023-12-01)

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022
by: A. V. Matveev, et al.
Published: (2024-01-01)

Reproductive issues in women on direct oral anticoagulants
by: Jan Beyer‐Westendorf, et al.
Published: (2021-05-01)

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023-11-01)

Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
by: Ahmed El-Bardissy, et al.
Published: (2025-01-01)

Evaluation of Drug–Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models
by: Zhuan Yang, et al.
Published: (2024-11-01)

Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study
by: Jean Terrier, et al.
Published: (2023-09-01)

Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis
by: Marco Mele, et al.
Published: (2024-06-01)

Availability, use and development of animal models for the assessment of drug-drug interactions and safety of direct oral anticoagulants
by: Ipek KOMSUOGLU CELIKYURT
Published: (2018-08-01)

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
by: Alessandra M. Campos-Staffico, et al.
Published: (2022-11-01)

Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study
by: Dorotea Bozic, et al.
Published: (2023-08-01)

Risk of inpatient epistaxis admission related to oral anticoagulation medication use
by: Margaret B. Mitchell, et al.
Published: (2023-08-01)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
by: Giuseppe Coppola, et al.
Published: (2019-09-01)

Oral Anticoagulation in Patients with Chronic Liver Disease
by: Raluca S. Costache, et al.
Published: (2023-02-01)

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants
by: A. I. Mironova, et al.
Published: (2022-06-01)